Articles

ROOTONIX goes beyond domestic crowd funding to overseas

by Professional Writer Professional Writer


ROOTONIX (CEO DaeKweon Jung) is a professional scalp/skin care company.

New Volume Booster, introduced on the 27th by Rootonix on the domestic crowd funding site "Wadiz", achieved more than 6,270% funding success within 3 weeks of its release. 

Rootonix's Dr. Finger New Volume Booster is one of the few Scalp Care devices that recorded 6,270% in Korea's fierce funding market. 

In 2019, Rootonix released Volume Booster, the first-generation version of New Volume Booster product, and raised about 15 million won in funding. Rootonix actively reflected the opinions of supporters for product improvement in the newly introduced 'New Volume Booster' and supplemented/added functional parts such as the intuitive appearance of the head and higher absorption rate of cosmetics, and received a high response from supporters.  

With the growth of the scalp/skin home care market due to COVID-19, the popularity of New Volume Booster has risen, and high demand from home and abroad home care devices has led to a successful start.

Rootonix said, "Using domestic Wadiz funding as a stepping stone, we are aiming to export about 200,000 dollars from "Makuake," a Japanese crowd funding site." 

A Rootonix official said, "It is the result of an ambitious preparation by synthesizing the opinions of consumers in line with the rapidly rising home care market after Corona 19, and it will be an excellent means for domestic as well as overseas consumers to take care of the scalp and skin at the same time." said.

 

If you are looking for a home care device for hair and scalp care, you can find them at ROOTONIX.

 

Click here to contact ROOTONIX.

 

View more: ROOTONIX Smart Scalp Care Solution


Sponsor Ads


About Professional Writer Freshman   Professional Writer

0 connections, 0 recommendations, 46 honor points.
Joined APSense since, May 10th, 2017, From Seoul, South Korea.

Created on Jul 21st 2022 05:03. Viewed 178 times.

Comments

No comment, be the first to comment.
Please sign in before you comment.